ArticleFrontiers in oncology2024

Enfortumab vedotin-related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience.

Evangelia Vlachou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.